CLINICAL TRIALS PROFILE FOR ACOTIAMIDE

Clinical Trials for Acotiamide

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00764374 ↗	A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia	Completed	Astellas Pharma Inc	Phase 3	To examine the safety and efficacy of Z-338 (YM443) after long-term administration in patients with functional dyspepsia, and also to examine the pattern of long-term administration.
NCT00850746 ↗	A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults	Completed	Astellas Pharma Inc	Phase 1	This study evaluates whether YM443 causes any changes in the electrocardiogram of healthy adults.
NCT01973790 ↗	Phase III, Long-term, Open-label Safety Study of Z-338	Completed	Zeria Pharmaceutical	Phase 3	The primary objective of this study is to evaluate the long-term safety of 100 mg Z-338 TID in European subjects with FD.

Clinical Trial Conditions for Acotiamide

Condition Name

Condition Name
Intervention	Trials
Dyspepsia	3
Functional Dyspepsia	3
Healthy	1

Condition MeSH

Condition MeSH
Intervention	Trials
Dyspepsia	5
Gastritis	1

Clinical Trial Locations for Acotiamide

Trials by Country

Trials by Country
Location	Trials
Japan	2
Belgium	2
United States	1
Latvia	1
Russian Federation	1

Trials by US State

Trials by US State
Location	Trials
Washington	1

Clinical Trial Progress for Acotiamide

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
PHASE3	1
Phase 3	3
Phase 1	1

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	5
NOT_YET_RECRUITING	1
Recruiting	1

Clinical Trial Sponsors for Acotiamide

Sponsor Name

Sponsor Name
Sponsor	Trials
Astellas Pharma Inc	2
Zeria Pharmaceutical	2
Universitaire Ziekenhuizen Leuven	1

Sponsor Type

Sponsor Type
Sponsor	Trials
Industry	5
Other	3